Stand der Pharmakogenetik in der klinischen Arzneimitteltherapie-Reference-Cited by-同舟云学术

Stand der Pharmakogenetik in der klinischen Arzneimitteltherapie

Published:2006-10 Issue:10 Volume:49 Page:995-1003
ISSN:1436-9990
Container-title:Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
language:de
Short-container-title:Bundesgesundheitsbl.

Author:

Kirchheiner J.,Seeringer A.,Brockmöller J.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1007/s00103-006-0045-1.pdf

Reference42 articles.

1. Kalow W (2001) Pharmacogenetics, pharmacogenomics, and pharmacobiology. Clin Pharmacol Ther 70:1–4

2. Nuffield Council on Bioethics (2003) Pharmacogenetics ethical issues. The Dorset Press, 132 pages

3. Council for International Organizations of Medical Sciences (CIOMS) (2005) Pharmacogenetics—towards improving treatment with medicines. CIOMS, 224 pages

4. Nationaler Ethikrat (2004) Stellungnahme Biobanken für die Forschung. Nationaler Ethikrat, Berlin, 120 Seiten

5. Evans WE, McLeod HL (2003) Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 348:538–549

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bewertung der Einsparpotenziale in der Arzneimitteltherapie durch Dosisanpassung an die Polymorphismen im Cytochrom P450;PharmacoEconomics German Research Articles;2012-06

2. Pharmacogenomics;Molecular Diagnostics: Promises and Possibilities;2009-11-27

3. Pharmacogenetics of Crohn’s disease;Pharmacogenomics;2008-07

4. CYP2D6-, CYP2C9- und CYP2C19-basierte Arzneimitteldosisanpassungen;Der Internist;2008-06-14

5. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice;Clinical Chemical Laboratory Medicine;2007-01-01